Dr. Tak Mak Receives Award for Cancer Research

MBP scientist Dr. Tak Mak and research collaborator Dr. Mark Davis of Stanford University have been awarded the prestigious 2021 Szent-Györgyi Prize for Progress in Cancer Research. The researchers are being recognized for their pioneering discovery and exploration of the T-Cell receptor, which, according to the National Foundation for Cancer Research (NFCI), has ‘formed a critical part of contemporary immuno-oncology and the molecular foundation for life-saving CAR (chimeric antigen receptor) T-cell therapies, a novel T-cell-based immunotherapy approach already approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of blood cancer’.

The Szent-Györgyi Prize for Progress in Cancer Research was established by the NFCR to ‘recognize outstanding scientists who have expanded our understanding of cancer and cancer causation’ and ‘whose vision has moved cancer research in new directions and whose discoveries have led to advances in cancer prevention, diagnosis or treatment’.

Please join the Department of Medical Biophysics in congratulating Dr. Mak on this outstanding achievement.

Learn more about the 2021 Szent-Györgyi Prize for Progress in Cancer Research on the NFCR website.